Systemic sclerosis, or scleroderma, afflicts about eight in 100,000 people in Asian populations. Read more at ...

Eventually, swallowing problems, constipation, improper nutrient absorption, and lung disease may develop. Systemic ...

Interstitial lung disease (ILD) causes significant morbidity and mortality in patients with systemic autoimmune rheumatic diseases. Patients at high risk of ILD should be screened using high ...

Much of the research on scleroderma, a connective tissue disease that causes scarring ... The leading cause of death in patients with scleroderma is lung fibrosis, according to Mouawad ...

Raynaud’s disease can also cause the fingers ... esophagus, heart, and lungs. Localized scleroderma is the mildest form. It does not affect the internal organs. There are two main types: morphea ...

some sort of scarring or damage to the lung tissue, within the lifetime of having that disease. The physiology of scleroderma causing fibrosis is complex. It's incompletely understood. We believe ...

Baylor Medicine’s Interstitial Lung Disease (ILD) program offers specialized and multidisciplinary ... For patients with connective tissue disorders (CTD) and ILDs (e.g., Rheumatoid arthritis, ...

lungs, blood vessels, digestive system, and nerves. People with MCTD have symptoms of several diseases, including lupus, scleroderma, polymyositis or dermatomyositis, and rheumatoid arthritis.

efzofitimod is a potential treatment for many interstitial lung diseases, Nangle explains. The aTyr team plans to explore treating other ILDs and is running a clinical trial now for scleroderma ...

A Des Moines woman who rode RAGBRAI is embarking on a new journey as she recovers from her recent double-lung ... scleroderma. Her body changed drastically as the rare autoimmune disease affected ...